about
Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophyABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human DiseaseGenomic profiling identifies novel mutations and SNPs in ABCD1 gene: a molecular, biochemical and clinical analysis of X-ALD cases in IndiaBezafibrate for X-linked adrenoleukodystrophyGene Therapy for Metabolic DiseasesX-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.HEREDITARY MYELOPATHIES.Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation.A three-year-old boy with X-linked adrenoleukodystrophy and congenital pulmonary adenomatoid malformation: a case report.alpha-Synuclein abnormalities in mouse models of peroxisome biogenesis disorders.Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia.Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophyVery long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy.Diagnosis of diseases of steroid hormone production, metabolism and action.Pathophysiology of X-linked adrenoleukodystrophy.ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapyAssessing children with ADHD in primary care settings.Exome sequencing identifies mutations in ABCD1 and DACH2 in two brothers with a distinct phenotype.MRI demyelination pattern and clinical course in a child with cerebral X-linked adrenoleukodystrophy (X-ALD).Bladder and Bowel Dysfunction Is Common in Both Men and Women with Mutation of the ABCD1 Gene for X-Linked Adrenoleukodystrophy.Induced pluripotent stem cells to model and treat neurogenetic disordersStem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.Onset of adreno-leukodystrophy after medulloblastoma therapy: causal connection or coincidence?The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesisPlasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatinClinical manifest x-linked recessive adrenoleukodystrophy in a female.Glutathione imbalance in patients with X-linked adrenoleukodystrophyA Novel Double Mutation in the ABCD1 Gene in a Patient with X-linked Adrenoleukodystrophy: Analysis of the Stability and Function of the Mutant ABCD1 Protein.25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome.Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.Clinical and genetic aspects in twelve Korean patients with adrenomyeloneuropathy.Stem cells in genetic myelin disorders.Myelin lesions associated with lysosomal and peroxisomal disorders.Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder.Treating inflammation in childhood neurodegenerative disorders.X-linked adrenoleukodystrophy in heterozygous female patients: women are not just carriers.Induced pluripotent stem cells for modeling of pediatric neurological disorders.Mitochondrial dysfunction in central nervous system white matter disorders.Imaging of adult leukodystrophies.Engineering Stem Cells for Biomedical Applications.
P2860
Q24618949-4755D076-829C-4E6D-B8B8-C80B48892C07Q28068772-1EB56E91-022A-4DC4-9D60-E6D396AEB784Q28477189-C0667530-1B48-4FFE-B2CB-87A661EC2FC2Q28481442-F7C31F50-D13E-4C07-ACC4-C3F85B73AAEAQ28595868-2B2245C2-1343-4CAC-BDD0-2C39CF43C957Q30460666-5805320C-E7B2-4C0F-9577-E659A1348304Q30483446-380160AA-CC6A-4ADD-8A56-75A424CE4569Q30572844-95F4EFEB-6561-4C4E-AE00-A7538174985FQ33601492-9EB957CE-9E17-48D6-B373-E6D25BF6B81EQ33643679-B7A961E0-80B9-4D07-AC7F-2C79919B995FQ33648258-56B12B77-E00C-4C0D-AB08-2913570A692DQ33897085-AD940A98-735E-4A6F-B1C8-C8C3C2ADD902Q33902055-7A81D036-7C59-4834-8D7B-4029B6E7523DQ34161154-EB04A1E8-49F7-4272-BA0E-250618A36A85Q34390414-7E20A2AB-3AA2-4C9B-8676-F56BBCFBDF81Q34598483-7482607D-9EB6-4A4D-946D-66CE15C19D0DQ34770323-FAC4BE72-FA4A-4105-BB0B-63DA8FAF1046Q35163395-9E3FA7DE-B369-4F90-949D-E94AA6E68057Q35264929-F6D5A196-5296-484A-8D47-53A19CE7309AQ35800962-3320DD9D-78F1-4526-A677-4A281A6CBB47Q36131883-EC79A22A-22D5-4A73-B30E-056EB292BF09Q36429491-9F684FDD-89B6-4A8D-A186-139BFCAECC5DQ36433274-8332AC32-785D-4514-94D8-F65F1D1877D5Q36632900-F5DADACE-3169-4003-8B75-958C1FFE2873Q36953948-29F243DF-B517-4CCD-A297-A7FF13FDEFD5Q36995509-D37780C0-F2B6-4FAA-A2EE-B13D82646859Q37066947-1E605C2F-3B79-458A-8201-D9230C7423A0Q37127693-3AF486CD-4338-4EF7-BCBE-11F5FF888AA9Q37389923-4A174F01-6109-4686-83B2-3412E509ECE7Q37605113-0CA5E6C5-C1F7-44CD-AAAF-CDA89EE90CDAQ37708247-81FC19D8-78C1-4268-9112-B78F1C051759Q37747349-F6CB38EA-CA68-43E3-8339-E39E3BA62B58Q37785556-E6EC4547-506B-471D-BD91-9E9985392DE8Q37798257-B0F98E47-D843-4377-A837-8EC5DE76EAC7Q37839130-8C634DE0-130C-43A3-9F45-8B59F7777345Q38029923-DD98648B-08A7-4C05-BF1C-76B85E2A7FA1Q38212628-72731C83-5CD6-48B8-A41F-BF0B242F2633Q38215315-143CB9B8-9F59-4D51-ACDC-B8508F946519Q38237452-8F8B7600-AFD7-4BCF-96AA-10CDF799A720Q38378499-6539F3C1-74C2-400B-834D-F268191B9964
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
X-linked adrenoleukodystrophy.
@ast
X-linked adrenoleukodystrophy.
@en
X-linked adrenoleukodystrophy.
@nl
type
label
X-linked adrenoleukodystrophy.
@ast
X-linked adrenoleukodystrophy.
@en
X-linked adrenoleukodystrophy.
@nl
prefLabel
X-linked adrenoleukodystrophy.
@ast
X-linked adrenoleukodystrophy.
@en
X-linked adrenoleukodystrophy.
@nl
P2093
P2860
P356
P1476
X-linked adrenoleukodystrophy.
@en
P2093
Asif Mahmood
Gerald V Raymond
Hugo W Moser
P2860
P2888
P304
P356
10.1038/NCPNEURO0421
P577
2007-03-01T00:00:00Z
P5875
P6179
1045448462